Tech & Gadgets

Biossil hits unicorn status with new OpenAI-led financing

30 sec read10 views0 listens

Toronto-based biotech firm Biossil has achieved unicorn status, securing $153 million USD in a funding round spearheaded by OpenAI’s Startup Fund. This development highlights the growing intersection of artificial intelligence and drug development, as Biossil utilizes AI to revive previously failed drug projects, offering a potentially faster and more efficient path to new treatments. Investors should watch for further details on Biossil's pipeline expansion and the specific AI-driven insights that will inform their clinical trials.

Read the full article at BetaKit

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

Ali NematiBlogUI.author_articles

BlogUI.view_profile

You Might Like

AI & Machine Learning10 hours ago34 sec read

Hold Back to the Last Good Check: Modelling Metal Detector Tests, Sieve Checks and Foreign Body Holds in a Food ERP

Food manufacturers in East Africa are implementing a new approach to foreign body detection, modeling metal detector checks as events linked to production lines and lots rather than simple checklist items. This system, designed to comply with food sa...

Ali Nemati

AI & Machine Learning10 hours ago32 sec read

How to Get a Transcript of Any YouTube Video (4 Free Methods)

Several free methods now exist to extract transcripts from YouTube videos. These tools leverage the video's caption track – either automatically generated by YouTube or uploaded by the creator – to provide text versions of the content. This developme...

Ali Nemati

AI & Machine Learning10 hours ago32 sec read

Hy Memory 2.0: Tencent's Open-Source Model That Only Remembers

Tencent has released Hy Memory 2.0, an open-source AI stack designed specifically to manage and retain information for AI agents. This development is significant for the AI/ML community because it represents a move towards modular AI architectures, a...

Ali Nemati